PMA supplement

P040029 S005: Euclid Systems Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear

FDA PMA supplement · 30-Day Notice · Euclid Vision Corporation

Key facts

Original PMA P040029
Supplement number S005
Supplement type 30-Day Notice
Reason for the supplement Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name Euclid Systems Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear
Generic name Lens, contact, orthokeratology, overnight
Applicant Euclid Vision Corporation
Product code NUU
Received date Aug 9, 2017
Decision date Sep 5, 2017

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements